In Savannah, Augusta, Columbus, and Macon, options are more limited but still available through primary care practices and some specialist clinics
Details For Those Who Want To Dive Deeper: Semaglutide and Cardiovascular Risk: What the Evidence Shows Semaglutide, a medication originally developed for weight management and diabetes treatment, has emerged as a powerful tool for reducing cardiovascular risk
Additionally, new therapeutic methods such as immunotherapy and epigenetic modification are being investigated in many labs, including ours
Our healthcare professionals tailor the dosing schedule to your personal needs and goals, making the treatment convenient while ensuring maximum effectiveness
Zepbound has not been studied in patients with a history of pancreatitis